As genomic research into the causes and treatments of disease moves rapidly into the era of personalised medicine, an increasing number of biomedical studies are searching for biomarkers to aid in the rapid and efficient prediction of susceptibility, diagnosis, prognosis and treatment of disease tailored to an individual.
Although the term biomarker is a relatively recent development, the Victorian Cancer Biobank has been banking samples of suitable quality for biomarker studies since 2000. The VCB has future proofed thousands of samples by storing mirror collections at both -80°C and liquid nitrogen temperatures, which are routinely called for in biomarker studies.
Cell line, Organoid, PDC development
Drug Target Validation
Explore our impacts to find out how researchers have created impact towards advancement in cancer discoveries through our support.
Contact us to learn more other applications or discuss about your research needs with us.